In silico identification and in vitro validation of nogalamycin <i>N</i>_oxide (NSC116555) as a potent anticancer compound against non�small_cell lung cancer cells

Simple item page
dc.contributor.authorPhongphat Obounchoey
dc.contributor.authorLueacha Tabtimmai
dc.contributor.authorPraphasri Suphakun
dc.contributor.authorKannika Thongkhao
dc.contributor.authorChatchakorn Eurtivong
dc.contributor.authorMatthew Paul Gleeson
dc.contributor.authorKiattawee Choowongkomon
dc.date.accessioned2025-07-21T06:00:38Z
dc.date.issued2018-10-15
dc.identifier.doi10.1002/jcb.27605
dc.identifier.urihttps://dspace.kmitl.ac.th/handle/123456789/7827
dc.subjectDocking (animal)
dc.subjectEGFR Inhibitors
dc.subject.classificationLung Cancer Treatments and Mutations
dc.titleIn silico identification and in vitro validation of nogalamycin <i>N</i>_oxide (NSC116555) as a potent anticancer compound against non�small_cell lung cancer cells
dc.typeArticle

Files

Collections

All